TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2020

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.

Li-Tzong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.